comparemela.com

Latest Breaking News On - Julia foldi - Page 1 : comparemela.com

Dr Foldi on T-DXd and Sacituzumab Govitecan in Metastatic Breast Cancer

Julia Foldi, MD, PhD, discusses the utility of of T-DXd and sacituzumab govitecan in the treatment of metastatic HER2-low and triple-negative breast cancer.

Dr Foldi on the Impact of ILD in HER2+ Breast Cancer Treatment

Julia Foldi, MD, PhD, discusses interstitial lung disease associated with the use of T-DXd in HER2+ breast cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.